期刊
EMERGING INFECTIOUS DISEASES
卷 16, 期 9, 页码 1349-1356出版社
CENTERS DISEASE CONTROL
DOI: 10.3201/eid1609.091389
关键词
-
资金
- Institut National de la Sante et de la Recherche Medicale, France
- Ministere de l'Education Nationale et de la Recherche, Universite Paris XI, Paris [UPRES-EA3539]
- Assistance Publique-Hopitaux de Paris, France
- European Community [HEALTH-F3-2008-223031]
Klebsiella pneumoniae isolates that produce carbapenemases (KPCs) are rapidly disseminating worldwide. To determine their genetic background, we investigated 16 bla(KPC-2)-harboring K. pneumoniae isolates from 5 countries. The isolates were multidrug resistant, possessed the bla(KPC-2) gene, and differed by additional beta-lactamase content. They harbored a naturally chromosome-encoded bla gene (bla(SHV-1) [12.5%], bla(SHV-11) [68.7%], or bla(OKP-A/B) [18.8%]) and several acquired and plasmid-encoded genes (bla(TEM-1) [81.3%], bla(CTX-M-2) [31.3%], bla(CTX-M-12) [12.5%], bla(CTX-M-15) [18.7%], and bla(OXA-9) [37.5%]). The bla(KPC-2) gene was always associated with 1 of the Tn4401 isoforms (a, b, or c). Tn4401 was inserted on different-sized plasmids that belonged to different incompatibility groups. Several bla(KPC)-containing K. pneumoniae clones were found: 9 different pulsotypes with 1 major (sequence type 258) and 7 minor distinct allelic profiles. Different clones harboring different plasmids but having identical genetic structure, Tn4401, could be at the origin of the worldwide spread of this emerging resistance gene.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据